Sustained Favorable Impact of Mavacamten on Biomarkers for Cardiopulmonary Stress and Hemolysis in Patients With Obstructive Hypertrophic Cardiomyopathy From the Mava-lte (explorer Cohort) and Valor-hcm Studies
Year: 2025
Type: article
Abstract: Mavacamten improved cardiac functionand symptoms in patients with obstructive Hypertrophic Cardiomyopathy (HCM) in MAVA-LTE and VALOR-HCM, while favorable circulating proteomic profile changes were observed following mavacamnten treatment in EXPLORER-HCM.
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $7,166
OpenAlex ID: W4408961784